Blog
    Condition FocusFor PatientsAugust 11, 2026

    Do peptides for gut health and inflammation work?

    Learn about the evidence for Larazotide Acetate and KPV. Understand current research findings on celiac disease, inflammation, and gut barrier function.

    What is going on down there?

    Living with gut issues often feels like your stomach is auditioning for a heavy metal band. Whether you are dealing with celiac disease or general inflammation, the search for relief is real.

    Recently, a few peptides have popped up in conversations about gut health. While the science is still very much in the "early days" phase, there are two specific names you might hear.

    Larazotide Acetate: The gatekeeper for gluten

    If you have celiac disease, you know the drill: stay away from gluten or pay the price. Scientists looked at Larazotide Acetate, which is a locally acting peptide. This means it works right there in your gut rather than traveling through your whole body.

    Here is how it is supposed to work:

    • Stabilizes tight junctions: Think of your gut lining like a fence. This peptide tries to keep the gates in that fence closed so things do not leak through.
    • Reduces permeability: This is just a fancy way of saying it tries to keep the gut barrier strong.
    • Helps with symptoms: In human studies, people taking a low dose alongside a gluten-free diet saw some modest improvement in their symptoms.

    However, it is not all smooth sailing. While the safety looked good, a major Phase III study was stopped because the results were not different enough from a placebo. It has not been proven to actually repair the gut or fix "leaky gut" in general. It currently has a Grade: B- on our scale.

    KPV: The laboratory experiment

    Then there is KPV, which is a tiny fragment of a larger hormone. In theory, KPV is supposed to block NF-kB translocation. In plain English, it tries to stop the body from sending signals that create inflammation.

    Here is the catch: scientists are still working on this one. It turns out the human body is complicated. While it showed some promise in models for Inflammatory Bowel Disease (IBD), we have zero human clinical trials. We do not even know how the human body processes it or how pure the versions made in labs actually are. Because of this total lack of human data, it sits at a Grade: D+.

    What should you do next?

    The gut is a sensitive place, and these peptides are still categorized as investigational or not approved.

    • Larazotide Acetate is not FDA-approved and its major trial was discontinued in 2022.
    • KPV is preclinical only, meaning it has not been tested in humans at all.

    This is a great one to bring up with your doctor. You can find peptide-experienced physicians in our Find a Doctor directory.

    This content is sourced exclusively from TruthTides clinical reference data and does not constitute medical advice.

    Referenced Peptides

    This content was generated from TruthTides clinical reference data. It does not constitute medical advice. Always consult a qualified healthcare provider.